Dr Philip is a physician scientist and oncology precision medicine expert renowned for his
expertise in cancer pathways and cancer genomics. With frontline experience in the NHS, he has
been actively involved in cancer clinical trials and the development of diagnostic and therapeutic
pathways.
Currently serving as the Chief Scientific Officer for Step Pharma, Dr Philip collaborates with esteemed institutions such as Hull Medical School, the NHS, Mayo Clinic Rochester USA, and the Wellcome Trust. His collaborative efforts span various aspects of genomics and precision medicine.
Dr Philip boasts a strong publication history, encompassing academic research, editorials/reviews, clinical guidelines, and book chapters. His contributions have significantly advanced our understanding of genomics in oncology and paved the way for improved cancer treatments and patient outcomes.